ELF made a statement in September 2021 about the purchase of the company Vectura, which produces inhalers, by Philip Morris International, a tobacco company. https://europeanlung.org/en/news-and-blog/elf-response-to-sale-of-vectura-to-philip-morris-international/.
Now a document has been developed by a number of organisations in the UK, including Asthma UK and British Lung Foundation (now Asthma and Lungs UK), to provide advice to people who want to know if their inhaler is affected and what to do if they want to change. https://www.asthmaandlung.org.uk/vectura-patient-information
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79